ADAM33 gene polymorphisms identified to be associated with asthma in a Chinese Li population

  • Authors:
    • Bo Shen
    • Rong Lin
    • Cai‑Chun Wang
    • Jing Rei
    • Yan Sun
    • Yong‑Le Yang
    • Ying‑Ying Lin
  • View Affiliations

  • Published online on: February 8, 2017     https://doi.org/10.3892/br.2017.854
  • Pages:323-328
0

Abstract

A disintegrin and metalloprotease 33 (ADAM33) is an asthma susceptibility gene that has been proven to be present in certain human populations. The Li population is a minority ethnic group, most of whom maintain a distinctive lifestyle on Hainan Island in southern China. To the best of our knowledge, no previous study has established whether ADAM33 polymorphisms are associated with asthma in the Li population. Therefore, the ADAM33 polymorphisms in a Li population were investigated in the present study. A total of 150 asthma patients and 100 healthy subjects were enrolled in the present study, and their DNA samples were evaluated to analyze eight single‑nucleotide polymorphisms (SNPs) on the ADAM33 gene. Asthma patients were subcategorized into low and high severity groups, and their SNP data were compared with the data of the control subjects. Single‑marker and haplotype association was analyzed to demonstrate the association between ADAM33 SNPs and asthma using multiple genetic statistic tests. The results indicated significant differences in allele frequencies at the SNPs rs44707/T2 (P=0.008), rs2787094/V4 (P=0.028) and rs2280089/T+1 (P=0.021) between asthma patients and control subjects. The SNP rs44707/T2 was also found to be associated with the high severity group (P=0.024), although SNPs rs2787094/V4 were associated with the low severity group (P=0.019). Two haplotypes, GGAGAGT and GAAGGGT, were significantly associated with asthma (P=0.003 and 0.008, respectively). To the best of our knowledge, this is the first time that SNP rs2280089/T+1 has been reported to be associated with asthma in an Asian population. These data confirm that ADAM33 polymorphisms are associated with asthma susceptibility in the Li population and confirm the uniqueness of the Li minority population within China.

Introduction

Asthma is a chronic inflammatory disease of the airway. More than 100 million people across the globe suffer from this disorder (Global strategy for asthma management and prevention; http://www.ginasthma.org). Airway inflammation, bronchial hyperresponsiveness (BHR), and reversible airflow obstruction are the primary characteristics of asthma. Among these, airway inflammation is most closely associated with the clinical symptoms. Currently, genetic and environmental factors have been found to be involved in the generation of asthma pathologies. Thus, the potential contribution of genetic factors is considered to be an interesting area of clinical and basic research.

The A disintegrin and metalloprotease 33 (ADAM33) gene is an asthma susceptibility gene, which was first reported by Van Eerdewegh et al (1). The ADAM33 gene is mapped to the short arm of chromosome 20p13 in the human genome, and is predominantly expressed in airway smooth-muscle cells and lung fibroblast cells, but not in epithelial cells, T cells or inflammatory leukocytes (26). ADAM proteins are involved in cell-cell and cell-matrix interactions (5), cell migration (2,3), cell-cell adhesion and signal transduction (4). The following are characteristic of ADAM33: Protease activity, a domain structure composed of a signal sequence, a prodomain, a metalloprotease domain, a transmembrane domain, a cysteine-rich domain, a disintegrin domain and a cytoplasmic domain (6). At present, >100 single-nucleotide polymorphisms (SNPs) of the ADAM33 gene have been reported to be associated with asthma or BHR (718). However, the data that demonstrate the association of ADAM33 SNPs with asthma were obtained from individuals living in mainland areas, who were predominantly Caucasian and Asian (10,11,1921), while there is little data on ADAM33 SNPs and asthma for ethnic minorities, particularly those living in isolated islands who seldom intermix with other ethnic groups. The Li population is a unique ethnic minority whose members live only on the Hainan Island in southern China. Various lines of evidence have shown there to be various specific genetic variations in the Li population, differentiating it from the Han population, even from the Han population from the same island (2225). Therefore, in the present study, the prevalence and types of ADAM33 polymorphisms in the asthmatic individuals of the Li population were determined and compared with those in the control subjects.

Materials and methods

Study participants

The present study was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all individuals and the protocols in the study were approved by the College's Ethics Committee (approval ID. HNMCE10011-9). Asthma was diagnosed according to the Global Initiative for Asthma (GINA) criteria (Global strategy for asthma management and prevention; http://www.ginasthma.org). The Li population study subjects were recruited between March 2008 and October 2013 from The People's Hospital of Sanya City (Sanya, China). A total of 150 patients with asthma (92 men and 58 women; mean age, 22.37 years) and 100 healthy controls (59 men and 41 women; mean age, 21.71 years) were enrolled. Subjects with asthma exhibited a mean forced expiratory volume in 1 sec (FEV1) of 1.79 l (64.58% of predicted), a mean forced vital capacity (FVC) of 2.37 l (79.82% of predicted), and a mean FEV1/FVC of 79.64%. The mean duration of asthma was 9.27 years. No significant difference between asthma patients and the normal controls was noted, except for lung function parameters. Pregnant and lactating women were excluded from the current study.

Extraction of the DNA samples

Clinical data and peripheral blood samples (5 ml per subject) were obtained from 150 unrelated asthma patients from the Li population and 100 unrelated healthy individuals who had no history of asthma. The genomic DNA samples were extracted from the peripheral blood of the subjects using a Mammalian Genomic DNA Miniprep kit (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) and the DNA samples were stored at −80°C.

Polymerase chain reaction (PCR) and sequencing analysis

PCR-restriction fragment length polymorphism was performed to analyze the ADAM33 SNPs using eight pairs of primers (Table I) as reported previously (26,27). PCR reactions were performed in a 25 µl system, as described previously (27). The PCR was run for 40 cycles of denaturation at 94°C for 30 sec, annealing at the optimal melting temperature (60–65°C) for 30 sec and extension at 72°C for 1 min on a T-Gradient ThermoBlock (Biometra GmbH, Göttingen, Germany). In addition, sequencing of the resultant PCR products was performed by a commercial biotech company (Takara Biotechnology Co., Ltd., Dalian, China) to confirm the exact alleles.

Table I.

General information and oligonucleotide primers used for the amplification of ADAM33 SNPs.

Table I.

General information and oligonucleotide primers used for the amplification of ADAM33 SNPs.

rs numberSNPAllelesPrimers (5′-3′)Length of enzyme and digested area (bp)
rs44707T2G >AF: TTCTCAGGGTCTGGGAGAAA HpyCH4III
R: GCCAACCTCCTGGACTCTTAA:198+112, G:310
rs511898F+1C >TF: GTATCTATAGCCCTCCAAATCAGAAGAGCCBsmBI
R: GGACCCTGAGTGGAAGCTGC:208+192, T:400
rs528557S2G >CF: AGAGCTCTGAGGAGGGGAACCGFseI, C:148+156
R: GCAGACCATGACACCTTCCTGCTGG:304
rs612709Q-1G >AF: GGATTCAAACGGCAAGGAGBtsCI, A:20+138
R: GTTCACCTAGATGGCCAGGAG:158
rs2280089T+1G >AF: CTGAGCCCAGAAACCTGATTHpyAV, A:284+28,
R: AGAAGGGAAGGGCTCATGCG:312
rs2280091T1A >GF: ACTCAAGGTGACTGGGTGCTNcoI, A:140+260,
R: GAGGGCATGAGGCTCACTTGG:400
rs2787094V4C >GF: CTCAGGAACCACCTAGGGGAGAAGPstI, G:168+206,
R: CAAAGGTCACACAGCCCCTGACCTC:374
rs3918396S1G >AF: TGTGCAGGCTGAAAGTATGCHinfI, G:132+172,
R: AGAGCTCTGAGGAGGGGAACA:304

[i] ADAM33, A disintegrin and metalloprotease 33; SNP, single nucleotide polymorphism; F, forward; R, reverse.

Statistical analysis

The software SNPAnalyzer (version 2.0; Istech, Kyungkido, Korea) was used to calculate Lewontin's D' value, and analyze the linkage disequilibrium (LD) and eight ADAM33 SNPs. Hardy-Weinberg equilibrium was confirmed via the exact distribution of allele frequencies using the χ2 test. P<0.05 was considered to indicate a statistically significant difference. The online software Haploview (http://www.broad.mit.edu/mpg/haploview) was used to construct the haplotype block. In addition, haplotype association analysis was conducted in two steps, as previously described (7,27). In order to determine whether ADAM33 polymorphisms are associated with the severity of asthma, the asthma patients were further sub-categorized into high and low severity groups. The high severity group included subjects suffering from moderate to severe persistent asthma, whereas the low severity group consisted of subjects with intermittent and mild persistent asthma. The participants were diagnosed according to the GINA criteria (http://www.ginasthma.org).

Results

Demographic characteristics of study subjects

A total of 150 patients suffering from asthma (92 men and 58 women; mean age, 22.37 years) and 100 healthy control subjects (59 men and 41 women; mean age, 21.71 years) were enrolled into the current study and the SNPs of their ADAM33 genes were analyzed. The major demographic characteristics are presented in Table II. The mean duration of asthma was 9.27 years. The demographic and lung function data indicated that the asthma patients had significantly lower lung function parameters than the healthy control subjects. The mean FEV1 and mean FVC in asthma patients were 1.79 l (64.58% of predicted) and 2.37 l (79.82% of predicted), respectively. To determine whether ADAM33 gene polymorphisms are associated with the severity of asthma, the asthmatic patients were divided into a high severity group and low severity group. As shown in Table III, the age of the asthma patients in the high severity group was significantly older than that in the low severity group (P<0.0001), and the periods during which the patients had suffered from asthma in the high severity group was longer than in the low severity group (P=0.006). In addition, the mean FEV1 in the high severity group was significantly lower than that in the low severity group (P <0.0001).

Table II.

Demographic characteristics of the asthmatic patients (n=150) and control subjects (n=100).

Table II.

Demographic characteristics of the asthmatic patients (n=150) and control subjects (n=100).

CharacteristicCaseControlP-value
Age (years)22.37±19.7221.71±20.640.482a
Gender (M/F)92/5859/410.819b
Duration of asthma (years)9.27±3.28
Pack year of smoking31.53±6.2229.57±5.810.052a
FVC (% of predicted)79.82±15.6694.81±8.42 <0.0001a
FEV1 (% of predicted)64.58±13.8592.77±7.52 <0.0001a

{ label (or @symbol) needed for fn[@id='tfn2-br-0-0-854'] } Values for age, smoking status, FVC and FEV1 are expressed as means ± standard deviation. The value for gender is expressed as the ratio between males and females. P-values obtained by

a t-tests

b Fisher's exact test. M, male; F, female; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 sec.

Table III.

Demographic characteristics of the asthmatic patients in high (n=62) and low (n=88) severity groups.

Table III.

Demographic characteristics of the asthmatic patients in high (n=62) and low (n=88) severity groups.

CharacteristicHigh severityLow severityP-value
Age (years)31. 27±18.8320.61±19.21 <0.0001a
Gender (M/F)38/2450/380.361b
Duration of asthma (years)11.57±9.057.82±5.990.006a
FVC (% of predicted)78.94±17.2282.41±20.790.091a
FEV1 (% of predicted)57.41±14.9177.35±16.33 <0.0001a

{ label (or @symbol) needed for fn[@id='tfn5-br-0-0-854'] } Values for age, duration of asthma FVC and FEV1 are expressed as mean ± standard deviation. The value for gender is expressed as the ratio between males and females. P-values obtained by

a t-tests

b Fisher's exact test. M, male; F, female; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 sec.

Genotype frequencies

Eight ADAM33 SNPs, including rs44707/T2, rs511898/F+1, rs528557/S2, rs612709/Q-1, rs2280089/T+1, rs2280091/T1, rs2787094/V4 and rs3918396/S1 have been reported to be associated with asthma in many of the world's mainland areas, and the majority of studies were performed on Caucasians and Asian individuals (10,11,1921). In the present study, genotyping of these eight ADAM33 SNPs was performed to evaluate the association with asthma in a Chinese Li population. These data indicated that all eight ADAM33 SNPs were present and distributed in Hardy-Weinberg equilibrium in the Li population. The genotype frequencies of each SNP are presented in Table IV.

Table IV.

Genotype frequencies of ADAM33 SNPs in the Li population.

Table IV.

Genotype frequencies of ADAM33 SNPs in the Li population.

Genotype [Case (n = 150)/control (n=100)]

SNP IDSNPHomozygous (wild-type)HeterozygousHomozygous (variant)
rs44707T2GG (82/71)GA (58/21)AA (10/8)
rs511898F+1CC (51/46)CT (81/42)TT (18/12)
rs528557S2GG (48/39)GC (78/41)CC (24/20)
rs612709Q-1GG (66/54)GA (74/38)AA (10/8)
rs2280089T+1GG (80/75)GA (59/19)AA (11/6)
rs2280091T1AA (121/87)AG (28/13)GG (1/0)
rs2787094V4CC (83/73)CG (60/19)GG (8/7)
rs3918396S1GG (148/98)GA (2/1)AA (0/1)

[i] ADAM33, A disintegrin and metalloprotease 33; SNP, single nucleotide polymorphism.

ADAM33 polymorphisms and association with asthma. Among the eight SNPs observed in the current study, the data shown in Table V demonstrated that only three SNPs, including rs44707/T2 (P=0.008), rs2280089/T+1 (P=0.021) and rs2787094/V4 (P=0.028) were significantly different in the Li asthma patients when compared with the control subjects. All of these three ADAM33 SNPs were found to be associated with asthma in the dominant model. Notably, the association of rs2280089/T+1 with asthma was only observed in European and Latin American individuals (28). To the best of our knowledge, no previous study has demonstrated such an association in Asian individuals (28) and this is the first time that rs2280089/T+1 has been reported to be associated with asthma in an Asian population.

Table V.

ADAM33 polymorphisms with asthma susceptibility in the Li population.

Table V.

ADAM33 polymorphisms with asthma susceptibility in the Li population.

χ2 test

SNP IDSNPGenetic modelGenotypeOdds ratio (95% confidence interval)P-value
rs44707T2DominantGA + AA1.97 (1.12–3.29)0.008
GG
rs2280089T+1DominantGA + AA1.84 (1.14–3.21)0.021
GG
rs2787094V4DominantCG + GG1.78 (1.09–2.97)0.028
CC

[i] ADAM33, A disintegrin and metalloprotease 33; SNP, single nucleotide polymorphism.

Haplotype association with asthma

Three ADAM33 SNPs (rs44707/T2, rs2280089/T+1 and rs2787094/V4) that were statistically significant in the present study were selected to further analyze their haplotypes, which was performed using Haploview 4.2 software, as previously reported (26). The eight haplotypes with frequencies >2.0% were identified to be suitable for further analysis. Table VI demonstrates the frequency of GGAGAGT and GAAGGGT haplotypes to be significantly higher in the asthmatic patients than in the control subjects (P=0.003 and P=0.008, respectively). Furthermore, the SNPs rs44707/T2, rs2280089/T+1 and rs2787094/V4 demonstrated strong D' values in pair-wise LD analysis (D'=0.9012 between rs44707/T2 and rs2280089/T+1; D'=0.8931 between rs2280089/T+1 and rs2787094/V4; Fig. 1), confirming the validity of the present haplotype analysis.

Table VI.

Frequency of each haplotype from the five-marker model in the Li population.

Table VI.

Frequency of each haplotype from the five-marker model in the Li population.

Haplotype frequency

HaplotypeCase (n=150)Control (n=100)Combined (n=250)P-value
GGAGAGT0.280.110.250.003
GAAGGGC0.040.030.03NS
GGAGGGC0.030.010.02NS
GGACGGT0.120.090.10NS
GGACGGC0.040.050.04NS
GAAGGGT0.220.100.19   0.008
GAAGGAC0.090.080.09NS
GGGGAGT0.050.040.04NS

[i] NS, not significant.

Association of SNPs in high and low severity patients

In the present study, the asthma patients were sub-grouped into high and low severity groups, and the allele and genotype differences from healthy control subjects were analyzed. The clinical characteristics of the high and low severity groups are demonstrated in Table III. The data concerning allelic distribution analysis showed that allele frequencies differed significantly between the high severity group and the control group with respect to SNP rs44707/T2 (P=0.024; Table VII). In addition, the allele frequencies demonstrated significant differences between the low severity group and the control subjects for the SNP rs2787094/V4 (P=0.019; Table VII). However, no significant differences were noted between the high and low severity groups in the allele frequencies.

Table VII.

ADAM33 polymorphisms with asthma susceptibility in high and low severity patients in the Li population.

Table VII.

ADAM33 polymorphisms with asthma susceptibility in high and low severity patients in the Li population.

SNP IDSNPGenotypeHigh severity/control P-valueLow severity/control P-value
rs44707T2GA + AA0.024NS
GG
rs2280089T+1GA + AANSNS
GG
rs2787094V4CG + GGNS0.019
CC

[i] ADAM33, A disintegrin and metalloprotease 33; NS, not significant.

Discussion

Various previous studies have reported that ADAM33 is a positively cloned gene for asthma (718). Thus, it is necessary to study the association of ADAM33 and prevalence of asthma in different populations, particularly in those living in special geographical environments, such as China's Li population. There are 55 minority ethnic groups in China, including the Li population (~1.3 million), who reside primarily in the central and southwestern regions of Hainan Island in the South China Sea, of which they are the aboriginal inhabitants. The Li people have maintained much of their traditional lifestyle into the present day. Although certain members of the Li community have intermarried with other communities, such as the Han and Miao populations, most of the Li people have remained relatively isolated from other populations, meaning that they are likely to have retained any unique genetic traits. Thus, any genetic study of the Li people may help to promote personalized therapeutic strategies in Li patients. Currently, there is a dearth of data concerning the ADAM33 polymorphisms in the Li population. Thus, the aim of the present study was to evaluate the variations in the ADAM33 gene in the Li population. The present study focused on eight SNPs of the ADAM33 gene that have been reported to be significantly closely associated with asthma or airway hyperresponsiveness in several populations (28). Gene segments covering these eight ADAM33 gene SNPs were successfully amplified and the results indicated that three SNPs, rs44707/T2, rs2280089/T+1 and rs2787094/V4, were associated with asthma in a dominant model in a Li population.

ADAM33 is a polymorphic gene with >100 known SNPs (28). However, not all these SNPs are associated with asthma. A meta-analysis analyzed 14 SNPs of the ADAM33 gene in 29 case-control studies in different populations, and the results showed significant associations with the rs2280091/T1, rs2787094/V4, rs511898/F+1 and rs2280089/T+1 polymorphisms in the overall population (28). However, positive results were only found for the rs2280091/T1, rs2787094/V4, rs511898/F+1 and rs511898/T2 polymorphisms, and only in Asians, not European or Latin American individuals (28). In the current study, a specific phenomenon regarding ADAM33 SNPs involving rs2280089/T+1 was observed, which was also observed in European and Latin American individuals, but never in Asian individuals (28). To the best of our knowledge, this is the first study to report that rs2280089/T+1 is associated with asthma in an Asian population. Although the underlying mechanism behind the ADAM33 SNP remains unknown, this finding indicates that the Li population is a particularly unique minority population in China and the world.

In the present study, the data also demonstrated ADAM33 SNPs to be significantly closely associated with the severity of asthma in the Li population. When compared with the control subjects, significant associations with high severity asthma were found in SNP rs44707/T2 (P=0.024), whereas a significant association with low severity asthma patients was observed in SNP rs2787094/V4 (P=0.019). Therefore, the results are consistent with previous results where asthma patients demonstrated significant decreases in lung function over time (29).

Haplotypes contain specific information regarding potentially unique, unobserved predisposing variants in specific regions (28,30). In the present study, two common haplotypes, including GGAGAGT and GAAGGGT, were found to be asthma-predisposing variants in the Li population. Haplotype data obtained from other unrelated subjects showed there to be a significant association between specific ADAM33 haplotypes and asthma in Chinese Han, Chinese Uygur, Japanese and German populations, and with BHR in a Korean population (28). Furthermore, family-based studies of German asthmatic patients confirmed the association of the ADAM33 haplotype with asthma (17). However, a variety of haplotype analyses in asthma subjects have already been identified in different populations. The previous results suggested that a risk haplotype in one population may be a protective haplotype in another (28). However, in the present study, no significant differences were identified in the distribution of haplotypes between the high and low severity asthma groups. This may be due to the relatively small sizes of the asthmatic patient populations. In a previous study, >200 asthmatic subjects were observed over a period of >20 years, and the resultant data showed the ADAM33 gene SNPs to be associated with a decline in FEV1, indicating that the function of the ADAM33 gene may be involved in all pathologic steps, including asthma prevalence, severity, airway hyperresponsiveness, progression and prognosis (9). Various lines of evidence in previous studies indicated that overexpression of the ADAM33 gene (mRNA and protein) was seen in various types of cells in asthma patients, including airway smooth muscle cells, fibroblasts, mesenchymal cells and endothelial cells (26). Furthermore, data from previous studies have demonstrated that the expression of the ADAM33 gene may regulate the expression of transforming growth factor-β, which is a major cytokine expressed and excreted by bronchial macrophages, epithelial cells and mesenchymal cells for airway remodeling (31). A potential mechanism by which ADAM33 affects asthma may be associated with the regulation of airway inflammation, hyperresponsiveness and remodeling processes; however, the exact molecular mechanism requires further investigation.

In conclusion, these data demonstrated a positive association between ADAM33 gene SNPs and asthma prevalence in a Li minority population in southern China. These data strengthen the evidence from previous investigations and studies of other populations elsewhere in the world. Currently, the exact functions of the ADAM33 gene in the progress of asthma pathogenesis remain unknown. Further investigations are required to determine the exact mechanism and the exact role of the ADAM33 gene in asthma.

Acknowledgements

The present study was funded by the National Natural Science Foundation of China (grant no. 81460020). The authors would like to thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript.

References

1 

Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, Simon J, Torrey D, Pandit S, McKenny J, Braunschweiger K, et al: Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature. 418:426–430. 2002. View Article : Google Scholar : PubMed/NCBI

2 

Martin J, Eynstone LV, Davies M, Williams JD and Steadman R: The role of ADAM 15 in glomerular mesangial cell migration. J Biol Chem. 277:33683–33689. 2002. View Article : Google Scholar : PubMed/NCBI

3 

McFarlane S: Metalloproteases: Carving out a role in axon guidance. Neuron. 37:559–562. 2003. View Article : Google Scholar : PubMed/NCBI

4 

Seals DF and Courtneidge SA: The ADAMs family of metalloproteases: Multidomain proteins with multiple functions. Genes Dev. 17:7–30. 2003. View Article : Google Scholar : PubMed/NCBI

5 

White JM: ADAMs: Modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol. 15:598–606. 2003. View Article : Google Scholar : PubMed/NCBI

6 

Yoshinaka T, Nishii K, Yamada K, Sawada H, Nishiwaki E, Smith K, Yoshino K, Ishiguro H and Higashiyama S: Identification and characterization of novel mouse and human ADAM33s with potential metalloprotease activity. Gene. 282:227–236. 2002. View Article : Google Scholar : PubMed/NCBI

7 

Awasthi S, Tripathi P, Ganesh S and Husain N: Association of ADAM33 gene polymorphisms with asthma in Indian children. J Hum Genet. 56:188–195. 2011. View Article : Google Scholar : PubMed/NCBI

8 

Howard TD, Postma DS, Jongepier H, Moore WC, Koppelman GH, Zheng SL, Xu J, Bleecker ER and Meyers DA: Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. J Allergy Clin Immunol. 112:717–722. 2003. View Article : Google Scholar : PubMed/NCBI

9 

Jongepier H, Boezen HM, Dijkstra A, Howard TD, Vonk JM, Koppelman GH, Zheng SL, Meyers DA, Bleecker ER and Postma DS: Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clinical and experimental allergy. Clin Exp Allergy. 34:757–760. 2004. View Article : Google Scholar : PubMed/NCBI

10 

Lee JH, Park HS, Park SW, Jang AS, Uh ST, Rhim T, Park CS, Hong SJ, Holgate ST, Holloway JW and Shin HD: ADAM33 polymorphism: association with bronchial hyper-responsiveness in Korean asthmatics. Clin Exp Allergy. 34:860–865. 2004. View Article : Google Scholar : PubMed/NCBI

11 

Lee YH and Song GG: Association between ADAM33 T1 polymorphism and susceptibility to asthma in Asians. Inflamm Res. 61:1355–1362. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Noguchi E, Ohtsuki Y, Tokunaga K, Yamaoka-Sageshima M, Ichikawa K, Aoki T, Shibasaki M and Arinami T: ADAM33 polymorphisms are associated with asthma susceptibility in a Japanese population. Clin Exp Allergy. 36:602–608. 2006. View Article : Google Scholar : PubMed/NCBI

13 

Sadeghnejad A, Ohar JA, Zheng SL, Sterling DA, Hawkins GA, Meyers DA and Bleecker ER: Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers. Respir Res. 10:212009. View Article : Google Scholar : PubMed/NCBI

14 

Sakagami T, Jinnai N, Nakajima T, Sekigawa T, Hasegawa T, Suzuki E, Inoue I and Gejyo F: ADAM33 polymorphisms are associated with aspirin-intolerant asthma in the Japanese population. J Hum Genet. 52:66–72. 2007. View Article : Google Scholar : PubMed/NCBI

15 

Su D, Zhang X, Sui H, Lü F, Jin L and Zhang J: Association of ADAM33 gene polymorphisms with adult allergic asthma and rhinitis in a Chinese Han population. BMC Med Genet. 9:822008. View Article : Google Scholar : PubMed/NCBI

16 

Uh ST, Jang AS, Park SW, Park JS, Min CG, Kim YH, Park BL, Shin HD, Kim DS and Park CS: ADAM33 gene polymorphisms are associated with the risk of idiopathic pulmonary fibrosis. Lung. 192:525–532. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Werner M, Herbon N, Gohlke H, Altmüller J, Knapp M, Heinrich J and Wjst M: Asthma is associated with single-nucleotide polymorphisms in ADAM33. Clin Exp Allergy. 34:26–31. 2004. View Article : Google Scholar : PubMed/NCBI

18 

Xue W, Han W and Zhou ZS: ADAM33 polymorphisms are associated with asthma and a distinctive palm dermatoglyphic pattern. Mol Med Rep. 8:1795–1800. 2013.PubMed/NCBI

19 

Fan JG, Wang ZA and Zhao HX: The ADAM33 S2 polymorphism is associated with susceptibility to pediatric asthma in the Chinese Han population. Genet Test Mol Biomarkers. 19:573–578. 2015. View Article : Google Scholar : PubMed/NCBI

20 

Klaassen EM, Penders J, Jöbsis Q, van de Kant KD, Thijs C, Mommers M, van Schayck CP, van Eys G, Koppelman GH and Dompeling E: An ADAM33 polymorphism associates with progression of preschool wheeze into childhood asthma: A prospective case-control study with replication in a birth cohort study. PLoS One. 10:e01193492015. View Article : Google Scholar : PubMed/NCBI

21 

Zheng W, Wang L, Su X and Hu XF: Association between V4 polymorphism in the ADAM33 gene and asthma risk: A meta-analysis. Genet Mol Res. 14:989–999. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Ding Y, Yang D, Zhou L, He P, Yao J, Xie P, Lin D, Sun D, Sun P, Li Q, et al: Cytochrome P450 2C9 (CYP2C9) polymorphisms in Chinese Li population. Int J Clin Exp Med. 8:21024–21033. 2015.PubMed/NCBI

23 

Ding Y, Yang D, Zhou L, Xu J, Chen Y, He P, Yao J, Chen J, Niu H, Sun P and Jin T: Variants in multiple genes polymorphism association analysis of COPD in the Chinese Li population. Int J Chron Obstruct Pulmon Dis. 10:1455–1463. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Ding Y, Yang H, He H, Shi H, He P, Yan S and Jin T: Plasma adiponectin concentrations and adiponectin gene polymorphisms are associated with bronchial asthma in the Chinese Li Population. Iran J Allergy Asthma Immunol. 14:292–297. 2015.PubMed/NCBI

25 

Wang J, Wen J, Si-Ma-Yi MH, He YB, Tu-Er-Xun KL, Xia Y, Zhang JL and Wu-Shou-Er QM: Association of ADAM33 gene polymorphisms with asthma in the Uygur population of China. Biomed Rep. 1:447–453. 2013.PubMed/NCBI

26 

Tan J, Liu AP, Sun C, Bai YF and Lv F: Association of ADAM33 gene polymorphisms with COPD in the Mongolian population of China. Ann Hum Biol. 41:9–14. 2014. View Article : Google Scholar : PubMed/NCBI

27 

Thongngarm T, Jameekornrak A, Limwongse C, Sangasapaviliya A, Jirapongsananuruk O, Assawamakin A, Chaiyaratana N, Luangwedchakarn V and Thongnoppakhun W: Association between ADAM33 polymorphisms and asthma in a Thai population. Asian Pac J Allergy Immunol. 26:205–211. 2008.PubMed/NCBI

28 

Liang S, Wei X, Gong C, Wei J, Chen Z and Deng J: A disintegrin and metalloprotease 33 (ADAM33) gene polymorphisms and the risk of asthma: A meta-analysis. Hum Immunol. 74:648–657. 2013. View Article : Google Scholar : PubMed/NCBI

29 

Pino-Yanes M, Thakur N, Gignoux CR, Galanter JM, Roth LA, Eng C, Nishimura KK, Oh SS, Vora H, Huntsman S, et al: Genetic ancestry influences asthma susceptibility and lung function among Latinos. J Allergy Clin Immunol. 135:228–235. 2015. View Article : Google Scholar : PubMed/NCBI

30 

Cordell HJ: Estimation and testing of genotype and haplotype effects in case-control studies: Comparison of weighted regression and multiple imputation procedures. Genet Epidemiol. 30:259–275. 2006. View Article : Google Scholar : PubMed/NCBI

31 

Girodet PO, Dournes G, Thumerel M, Begueret H, Dos Santos P, Ozier A, Dupin I, Trian T, Montaudon M, Laurent F, et al: Calcium channel blocker reduces airway remodeling in severe asthma. A proof-of-concept study. Am J Respir Crit Care Med. 191:876–883. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

March 2017
Volume 6 Issue 3

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Shen, B., Lin, R., Wang, C., Rei, J., Sun, Y., Yang, Y., & Lin, Y. (2017). ADAM33 gene polymorphisms identified to be associated with asthma in a Chinese Li population. Biomedical Reports, 6, 323-328. https://doi.org/10.3892/br.2017.854
MLA
Shen, B., Lin, R., Wang, C., Rei, J., Sun, Y., Yang, Y., Lin, Y."ADAM33 gene polymorphisms identified to be associated with asthma in a Chinese Li population". Biomedical Reports 6.3 (2017): 323-328.
Chicago
Shen, B., Lin, R., Wang, C., Rei, J., Sun, Y., Yang, Y., Lin, Y."ADAM33 gene polymorphisms identified to be associated with asthma in a Chinese Li population". Biomedical Reports 6, no. 3 (2017): 323-328. https://doi.org/10.3892/br.2017.854